Cytomel (Liothyronine) Cost in Oklahoma 2026

What Does Cytomel (Liothyronine) Actually Cost in Oklahoma?

Generic liothyronine tablets cost an average of $35 per month at Oklahoma retail pharmacies in 2026 when paying cash. The Pfizer brand Cytomel carries a manufacturer list price near $120 per month, but almost no cash-pay patient pays that amount. Discount programs, coupon cards, and pharmacy-to-pharmacy price variation can move the final number by $10 to $25 in either direction.

Liothyronine is a synthetic form of triiodothyronine (T3), the active thyroid hormone. The FDA approved the original Cytomel label for hypothyroidism, pituitary TSH suppression, and thyroid diagnostic testing [1]. Generic liothyronine tablets in the 5 mcg, 25 mcg, and 50 mcg strengths are manufactured by several suppliers including Pfizer (Cytomel), Mylan, and Lannett. Because multiple generics compete in the same supply chain, retail prices in Oklahoma have remained low compared to many other thyroid medications [2].

A 2024 GoodRx analysis found that the average retail price for 30 tablets of liothyronine 25 mcg at major Oklahoma chains (Walmart, CVS, Walgreens, Reasor's) ranged from $18 to $55 before any coupon was applied [3]. Applying a free GoodRx coupon pushed that range down to approximately $12 to $35 at the same pharmacies. Prices at independent compounding pharmacies and mail-order services sit in a slightly different range, discussed below.

The American Thyroid Association notes that liothyronine formulations are not considered bioequivalent across all manufacturers, which means some clinicians specify a preferred generic on the prescription [4]. Switching manufacturers mid-treatment may shift TSH and free T3 values, so confirming the dispensing manufacturer at each fill is worth a quick call to your Oklahoma pharmacist.

Oklahoma Medicaid Coverage for Liothyronine

Oklahoma Medicaid (SoonerCare) does not cover Cytomel or generic liothyronine as of 2026. The SoonerCare preferred drug list (PDL) covers levothyroxine (T4 monotherapy) as the preferred thyroid replacement agent but excludes liothyronine from its formulary [5]. This aligns with the approach of most state Medicaid programs, which follow the 2014 American Thyroid Association guideline recommendation that levothyroxine monotherapy remain the standard of care for hypothyroidism [4].

Patients on SoonerCare who require liothyronine for documented clinical reasons can request a prior authorization (PA). The PA process through the Oklahoma Health Care Authority requires the prescribing provider to submit clinical documentation showing why levothyroxine monotherapy is insufficient [5]. Approvals are uncommon but not impossible, particularly for patients with documented residual symptoms on optimized T4 therapy or for those recovering from thyroid cancer surgery requiring TSH suppression.

If the PA is denied, three practical alternatives exist. First, cash-pay generic liothyronine at roughly $35 per month may be more affordable than pursuing an appeal for many patients. Second, a licensed 503A compounding pharmacy can prepare custom-dose liothyronine tablets at around $40 per month. Third, manufacturer savings cards from Pfizer (for Cytomel) or generic manufacturer cards may reduce out-of-pocket costs substantially for patients who otherwise qualify.

Research published in the Journal of Clinical Endocrinology and Metabolism found that approximately 5 to 10 percent of hypothyroid patients on adequate levothyroxine therapy continue to report impaired quality of life, which represents the primary clinical rationale for adding T3 [6]. Oklahoma clinicians familiar with this evidence sometimes pursue the PA pathway for exactly this population.

How Compounded Liothyronine T3 Works in Oklahoma

Compounded liothyronine from a licensed 503A pharmacy is legal in Oklahoma. It costs roughly $40 per month for a typical 25 mcg twice-daily regimen. Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed compounding pharmacies to prepare individualized preparations based on a valid patient-specific prescription [7].

Oklahoma's State Board of Pharmacy licenses and inspects 503A compounding pharmacies operating within the state. Prescriptions for compounded liothyronine must originate from a licensed prescriber and specify the dose, strength, base (usually a slow-release capsule or immediate-release tablet), and quantity. Oklahoma does not restrict compounded thyroid preparations beyond the federal 503A framework, meaning a physician, nurse practitioner, or physician assistant with Oklahoma prescribing authority can legally write these prescriptions [8].

The clinical rationale for compounded T3 includes dose flexibility. Commercial tablets come only in 5 mcg, 25 mcg, and 50 mcg strengths. Some patients stabilize on doses like 10 mcg or 17.5 mcg that require splitting or compounding. Slow-release (SR) compounded T3 formulations attempt to blunt the T3 peak seen with immediate-release tablets, though clinical trial data on SR T3 are limited and the FDA has not approved any sustained-release liothyronine product [9].

Bunevicius et al. published a landmark trial in the New England Journal of Medicine (1999) demonstrating that replacing 50 mcg of levothyroxine with 12.5 mcg of liothyronine improved mood and neuropsychological function in a crossover study of 33 patients [10]. That trial used a specific T4:T3 substitution ratio and remains one of the most-cited pieces of evidence supporting combination therapy. Subsequent larger trials have produced mixed results, but the Bunevicius study is still referenced in current ATA discussions of combination therapy [4].

One practical caution: not all Oklahoma compounding pharmacies carry USP-grade liothyronine active pharmaceutical ingredient (API). Asking the pharmacy directly about their API sourcing and COA (certificate of analysis) documentation before filling is a reasonable step, given that API quality directly affects dosing accuracy [7].

Insurance Coverage for Liothyronine in Oklahoma

Private insurance plans in Oklahoma treat liothyronine inconsistently. Coverage depends on the plan tier structure, the formulary year, and whether a prior authorization is required.

Most commercial plans in Oklahoma (including Blue Cross Blue Shield of Oklahoma, CommunityCare, and Aetna) place generic liothyronine on Tier 2 (preferred generic) or Tier 3 (non-preferred generic). Tier 2 copays typically run $10 to $30 per month after the deductible. Tier 3 copays run $30 to $60 per month [11]. Brand Cytomel, when covered at all, lands on Tier 3 or Tier 4, making generic substitution the financially rational default for most insured Oklahomans.

Employer-sponsored plans governed by ERISA may differ from state-regulated individual and small-group plans. Reviewing the Summary of Benefits and Coverage (SBC) document your employer provides each fall is the most direct way to determine your plan's 2026 tier placement for liothyronine. The FDA's Orange Book lists all currently approved liothyronine generics, which can help you confirm what your pharmacy is dispensing [12].

Prior authorization requirements for liothyronine have increased across Oklahoma commercial plans over the past three years. A PA typically requires documentation of a TSH below the normal range on levothyroxine alone, or a documented clinical indication beyond simple hypothyroidism (such as thyroid cancer follow-up or T3-specific diagnostic testing). Your HealthRX provider can prepare and submit this documentation on your behalf as part of a telehealth visit.

Oklahoma participates in the federal Health Insurance Exchange (Healthcare.gov). Silver-tier ACA marketplace plans in Oklahoma averaged $412 per month in 2025 premiums, according to CMS data [11]. Formulary tiers on Exchange plans vary by insurer, and the easiest way to check liothyronine coverage before enrolling is to use the plan finder's drug search tool at Healthcare.gov during open enrollment.

Telehealth Prescribing of Liothyronine in Oklahoma

Telehealth prescribing of liothyronine is legal in Oklahoma. Oklahoma enacted SB 1672 in 2022, which aligned state telehealth standards with the relaxed prescribing rules established during the COVID-19 public health emergency and made most of those rules permanent [13]. A licensed Oklahoma prescriber can evaluate a patient via synchronous video or telephone, order thyroid function labs, and prescribe liothyronine without an in-person visit.

The Oklahoma Medical Board and the Oklahoma Board of Nursing both permit their respective licensees to establish a patient-provider relationship via telehealth. The prescriber must still meet the standard of care for thyroid management, which the ATA defines as obtaining a baseline TSH, free T4, and free T3 before initiating liothyronine [4].

HealthRX operates telehealth services in Oklahoma. A new-patient thyroid evaluation includes a review of current labs (or an order for new labs at a partnered draw site), a video visit with a licensed clinician, and same-day electronic prescribing to any Oklahoma pharmacy the patient chooses. Follow-up visits at six to eight weeks post-initiation are standard protocol, consistent with the ATA recommendation that TSH and free T3 be rechecked four to eight weeks after any dose adjustment [4].

Telehealth visits for thyroid management at HealthRX are typically covered by commercial insurance under Oklahoma's telehealth parity law, which requires insurers to reimburse telehealth services at the same rate as equivalent in-person services [13]. Patients paying cash can expect a new-patient telehealth visit to cost less than a traditional endocrinology office visit, with significantly shorter wait times.

Savings Programs and Discount Cards for Oklahoma Patients

Several programs can reduce the out-of-pocket cost of liothyronine in Oklahoma, sometimes to under $15 per month.

GoodRx and RxSaver. Free coupon aggregator sites negotiate discounted rates with pharmacy benefit managers. At Oklahoma Walmart locations, GoodRx currently lists generic liothyronine 25 mcg (30 tablets) at approximately $12 to $18. Prices fluctuate weekly, so checking the site immediately before picking up a prescription is worthwhile [3].

Pfizer's Cytomel Savings Card. Pfizer offers a savings card for commercially insured patients that can reduce Cytomel copays to as low as $0 per month for eligible patients. Income-based eligibility requirements apply, and the card is not valid for patients using Medicaid, Medicare, or other federal programs. Details and enrollment are available through the Pfizer patient assistance portal [14].

NeedyMeds and RxAssist. For uninsured or underinsured Oklahoma patients who do not qualify for Medicaid but cannot afford retail prices, NeedyMeds and RxAssist maintain databases of manufacturer patient assistance programs (PAPs). Pfizer's PAP for Cytomel provides free medication to qualifying low-income patients. Applications require income verification and a provider signature [15].

Mark Cuban Cost Plus Drugs. Mark Cuban's Cost Plus Drugs pharmacy (costplusdrugs.com) sells generic liothyronine 25 mcg (90 tablets) for under $10 as of early 2026. Oklahoma residents can order by mail with a valid prescription. Shipping typically arrives within four business days. This option is available only for patients paying cash; Cost Plus does not bill insurance [3].

Oklahoma 340B Clinics. Federally qualified health centers (FQHCs) and other 340B-eligible providers in Oklahoma can access drug pricing discounts unavailable at retail pharmacies. Patients who receive primary care at a 340B clinic (such as Variety Care or NorthCare in Oklahoma City) may obtain liothyronine at substantially reduced cost through the clinic's in-house or contract pharmacy [16].

Clinical Context: Why Liothyronine Is Prescribed

Liothyronine is prescribed in Oklahoma primarily for three indications. Hypothyroidism adjunct therapy is the most common, where T3 is added to levothyroxine when patients have persistent symptoms despite normal TSH on T4 alone. TSH suppression after thyroid cancer surgery is the second indication, where supratherapeutic doses target TSH below 0.1 mIU/L per American Thyroid Association differentiated thyroid cancer guidelines [17]. Thyroid diagnostic testing (T3 suppression test and thyroid scan preparation) represents a narrower but established third use.

The standard starting dose for hypothyroidism adjunct therapy is 5 to 25 mcg per day, titrated at six-week intervals. A 2019 meta-analysis in Thyroid (N=470 across six randomized trials) found that T4 plus T3 combination therapy improved mood and psychological well-being compared to T4 monotherapy, though effects on body weight and cholesterol were minimal [18]. The absolute mean difference in quality-of-life scores was modest, underscoring that patient selection matters more than population-level averages.

Liothyronine has a short plasma half-life of approximately one day, compared to levothyroxine's seven-day half-life [2]. This pharmacokinetic difference is clinically meaningful: missed doses of liothyronine produce faster symptomatic decline than missed levothyroxine doses, and twice-daily dosing (rather than once daily) is generally preferred to minimize peak-to-trough T3 swings. The ATA's 2023 clinical practice guidelines note this pharmacokinetic limitation as a reason to individualize dosing schedules rather than apply a uniform protocol [4].

Cardiovascular safety deserves attention. Excess T3 can precipitate atrial fibrillation and worsen angina. A 2018 study in JAMA Internal Medicine (N=162,369) found that thyroid hormone overtreatment (TSH <0.1 mIU/L) was associated with a 2.2-fold increased risk of atrial fibrillation compared to patients with TSH within range [19]. Oklahoma prescribers managing liothyronine should obtain baseline ECG in patients over 60 or with known cardiovascular risk factors, and TSH monitoring every six to twelve months is standard once a stable dose is established [4].

Comparing Cost Options Side by Side

Understanding where each option sits relative to clinical goals helps Oklahoma patients and their prescribers make a practical choice.

Brand Cytomel at list price ($120/month) is rarely the right choice for cash-pay patients given identical generic bioequivalence for most indications. Generic liothyronine at $35/month cash or $12 to $18 with GoodRx covers the majority of straightforward combination-therapy patients. Compounded T3 at $40/month is justified when the patient requires a dose not available in commercial tablet strengths, or when the prescriber specifically orders a slow-release formulation for a patient experiencing T3 peak symptoms (palpitations, anxiety, sweating within two hours of dosing).

Mail-order through Cost Plus Drugs at under $10 for 90 tablets is the lowest-cost reliable option for patients who are consistent about refills and have a stable dose. The tradeoff is the absence of insurance billing and a four-day shipping window.

Oklahoma's patchwork of savings programs means that the cheapest route is rarely the same for every patient. A patient with Blue Cross Tier 2 coverage and a low deductible already met may pay less through insurance than through GoodRx. Conversely, a patient with a high-deductible plan who has not met their deductible in January will pay retail rates and should use a coupon card instead.

Pharmacists at Oklahoma independent pharmacies are often the most useful resource for real-time price comparison, since they can check multiple purchasing contracts simultaneously. The Oklahoma State Board of Pharmacy maintains a directory of licensed pharmacies, including 503A compounders, at pharmacy.ok.gov [8].